Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

The evolution of direct transcranial photobiomodulation: a history of dose, depth, and delivery

We distinguish focal-local, diffuse/systemic, and local-stimulation/network-mediated accounts of action and identify prospective tests that can discriminate among them.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This historical review traces how direct transcranial photobiomodulation evolved through decisions about optical access, target depth, and dose. The authors report that three NEST stroke trials gave mixed results, with one meeting its primary endpoint and another stopping for futility, and that later forehead studies used different light platforms and parameters. They conclude that dose, depth, and delivery site should be treated as biological variables, and that mechanisms remain unresolved.

Who or what was studied
unclear
Wavelengths
808 nm
Limits stated in the abstract
The abstract describes a historical reconstruction, the mechanistic evidence is described as unresolved, and one NEST-2 reanalysis is unpublished and exploratory.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Direct transcranial photobiomodulation (dtPBM) delivers red or near-infrared light through the scalp and skull with the aim of affecting brain tissue. The field has produced encouraging findings but inconsistent clinical results. We reconstruct its development as a history of scientific and engineering decisions in which optical access, target depth, and dose repeatedly shaped what could be tested. The clinical lineage began with light therapy for ischemic myocardium and moved to stroke, where cadaver measurements established that near-infrared light could traverse the human scalp and skull and defined a historical design target of approximately 7.5 mW/cm2 at the dura. The NEST clinical program then carried a fixed 808-nm regimen into three stroke trials: NEST-1 met its primary endpoint, NEST-2 showed a nonsignificant overall trend (p = 0.094) with a published post hoc signal in moderate stroke (p = 0.044), and NEST-3 stopped for futility. An unpublished, exploratory NEST-2 reanalysis described larger treatment differences for superficial lesions; this observation motivates prospective testing but does not establish depth-dependent efficacy. After NEST, treatment moved to the forehead, where target geometry was more reproducible. The ELATED trials adopted a more practical LED platform at substantially lower irradiance while preserving broadly similar treatment-site radiant exposure, whereas the TRIADE R61 trial deliberately varied optical parameters and found optical-parameter-dependent, bidirectional BOLD power responses. The historical record also leaves biological mechanism unresolved: mitochondrial/redox, neurovascular, glial-inflammatory, network-mediated, and diffuse or systemic pathways remain plausible at different levels of evidence, and a distributed physiological response does not by itself identify where the effect begins. These observations support a constrained historical inference: dose, depth, and delivery site are biological variables, not merely device specifications. We distinguish focal-local, diffuse/systemic, and local-stimulation/network-mediated accounts of action and identify prospective tests that can discriminate among them. The next phase of dtPBM development should prioritize indications in which optical access, target engagement, and a disease-relevant network or biomarker can be specified prospectively rather than inferred after a clinical outcome.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Power density (irradiance)
7.5 mW/cm2

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Dose, Transcranial photobiomodulation, Photobiomodulation, Stroke, Near-infrared, Light-emitting diode, Irradiance, Biomarker. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies